New sulfonated distamycin a derivatives with bFGF complexing activity

Biochemical Pharmacology

Volumn 47, Issue 2, 1994, Pages 295-302

  Ciomei, Marina ^a   Pastori, Wilma ^a   Mariani, Mariangela ^a   Sola, Francesco ^a   Grandi, Maria ^a   Mongelli, Nicola ^a  

^a PFIZER INC   (United States)

Author keywords

bFGF, basic fibroblast growth factor; BSA, bovine serum albumin; CAM, chorioallantoic membrane; EGF, epidermal growth factor; IL 1 , interleukin 1 ; MEM, minimum essential medium; PBS, phosphate buffered saline; PDGF , platelet derived growth factor ; TBS, Tris buffered saline; TNF , tumor necrosis factor

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; DISTAMYCIN A DERIVATIVE; EPIDERMAL GROWTH FACTOR; FCE 26580; FCE 26605; FCE 26644; FCE 26951; FCE 27111; FCE 27163; FCE 27164; FCE 27192; FIBROBLAST GROWTH FACTOR RECEPTOR; INTERLEUKIN 1BETA; PLATELET DERIVED GROWTH FACTOR BETA; SURAMIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING COMPETITION; CELL STRAIN 3T3; CHICK EMBRYO; CHORIOALLANTOIS; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG MECHANISM; EMBRYO; FIBROBLAST; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; STRUCTURE ACTIVITY RELATION;

3T3 CELLS; ANIMAL; BINDING, COMPETITIVE; COMPARATIVE STUDY; DISTAMYCINS; FIBROBLAST GROWTH FACTOR 2; MICE; MICE, INBRED BALB C; NEOVASCULARIZATION, PATHOLOGIC; PHOSPHORYLATION; STRUCTURE-ACTIVITY RELATIONSHIP; SULFONIC ACIDS; SUPPORT, NON-U.S. GOV'T; SURAMIN; TYROSINE;

EID: 0028155949     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(94)90020-5     Document Type: Article

References (34)

1. Angiogenesis and oncogenesis
2. Angiogenesis: a marker for neoplastic transformation of mammary capillary hyperplasia
3. What is the evidence that tumors are angiogenesis dependent?
4. Angiogenic factors
5. Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis
6. Suramin prevents neovascularisation and tumour growth through blocking of basic fibroblast growth factor activity
7. Suramin: an anticancer drug with a unique mechanism of action
8. Treatment of hormonally refractory prostate cancer with suramin
9. Effect of suramin in patients with refractory nodular lymphomas requiring systemic therapy
10. Differential inhibition of various deoxyribonucleic and ribonucleic acid polymerases by suramin
11. + ATPases by fusidic acid and suramin
12. Differential effects of suramin on the coupling of receptors to individual species of pertussis-toxin sensitive guanine-nucleotide-binding proteins
13. Suramin inhibition of growth factor receptor binding and mitogenicity in ARK-2B cells
14. Suramin binds to platelet-derived growth factor and inhibits its biological activity
15. Suramin prevents binding of interleukin 2 to its cell surface receptor: a possible mechanism for immunosuppression
16. Inhibitory effect of suramin on receptor binding and cytotoxic activity of tumor necrosis factor α
17. Suramin Blockade of Insulinlike Growth Factor I-Stimulated Proliferation of Human Osteosarcoma Cells
18. Autocrine transformation by chimeric signal peptide-basic fibroblast growth factor: reversal by suramin
19. Recent developments in the cell biology of basic fibroblast growth factor
20. A heparin-binding angiogenic protein—basic fibroblast growth factor—is stored within basement membrane
21. Human tumor cells synthesize an endothelial cell growth factor that is structurally related to basic fibroblast growth factor
22. An in vivo model for study of the angiogenic effects of basic fibroblast growth factor
23. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
24. A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment
25. Antagonistic effect of suramin on bFGF: in vitro and in vivo results
26. Human microvascular endothelial cells express receptors for platelet derived growth factors
27. Transforming growth factor-α: a more potent angiogenic mediator than epiderma growth factor
28. Effect of interleukin-1-β on metastasis formation in different tumor systems
29. Acidic and basic fibroblast growth factors stimulate tyrosine kinase activity in vivo
30. Suramin with special reference to onchocerciasis
31. Effect of suramin in patients with refractory nodular lymphomas requiring systemic therapy
32. Degeneration of the adrenal cortex produced by Germanin
33. Suramin-induced polyneuropathy